Recent Pre-Clinical Advancements in Nuclear Medicine: Pioneering the Path to a Limitless Future.

ABSTRACT: The theranostic approach in oncology holds significant importance in personalized medicine and stands as an exciting field of molecular medicine. Significant achievements have been made in this field in recent decades, particularly in treating neuroendocrine tumors using 177-Lu-radiolabeled somatostatin analogs and, more recently, in addressing prostate cancer through prostate-specific-membrane-antigen targeted radionuclide therapy. The promising clinical results obtained in these indications paved the way for the further development of this approach. With the continuous discovery of new molecular players in tumorigenesis, the development of novel radiopharmaceuticals, and the potential combination of theranostics agents with immunotherapy, nuclear medicine is poised for significant advanc

SUBMITTER: Echavidre W 

PROVIDER: S-EPMC10572076 | biostudies-literature | 2023 Oct

REPOSITORIES: biostudies-literature